Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Development and application of replication-incompetent HSV-1-based vectors.

E Berto1, A Bozac, P Marconi

  • 1Department of Experimental and Diagnostic Medicine, Section of Microbiology, University of Ferrara, Ferrara, Italy.

Gene Therapy
|October 19, 2005
PubMed
Summary

Replication-incompetent herpes simplex virus-1 (HSV-1) vectors offer a promising gene therapy tool. These modified viruses enable simultaneous expression of multiple therapeutic genes, demonstrating potential in treating neurological disorders and cancers.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Constitutive phosphorylation of the active Notch1 intracellular domain in chronic lymphocytic leukemia cells with NOTCH1 mutation.

Leukemia·2014
Same author

Development of replication-defective herpes simplex virus vectors.

Methods in molecular medicine·2014
Same author

A revised NOTCH1 mutation frequency still impacts survival while the allele burden predicts early progression in chronic lymphocytic leukemia.

Leukemia·2013
Same author

[Improving dietary habits in the effective prevention of excess weight and obesity].

Annali di igiene : medicina preventiva e di comunita·2012
Same author

A battery-operated, stabilized, high-energy pulsed electron gun for the production of rare gas excimers.

The Review of scientific instruments·2011
Same author

A food borne outbreak of Salmonella enterica serotype Brandenburg as a hint to compare human, animal and food isolates identified in the years 2005-2009 in Italy.

Journal of preventive medicine and hygiene·2011

Area of Science:

  • Biotechnology
  • Gene Therapy
  • Virology

Background:

  • Herpes simplex virus type 1 (HSV-1) vectors are engineered for gene therapy by mutating or deleting essential replication genes.
  • These modifications reduce viral cytotoxicity and create space for transgene expression cassettes.

Purpose of the Study:

  • To develop replication-incompetent HSV-1 vectors for gene therapy applications.
  • To assess the therapeutic potential of these vectors in various disease models.

Main Methods:

  • Engineering HSV-1 to be replication-incompetent through gene mutation/deletion.
  • Developing distinct, independently regulated expression cassettes for transgenes.
  • Testing vectors in animal models for neuropathies, lysosomal storage disorders, and cancer.

Related Experiment Videos

Main Results:

  • Replication-incompetent HSV-1 vectors demonstrate reduced cytotoxicity and enhanced capacity for transgene delivery.
  • Successful preclinical testing in models of Parkinson's disease, chronic pain, spinal cord injury, and lysosomal storage disorders.
  • Application as anti-herpes vaccines and vaccine vectors for other pathogens, alongside successful anticancer gene therapy approaches.

Conclusions:

  • Replication-incompetent HSV-1 vectors are versatile tools for gene therapy, enabling synergistic expression of multiple therapeutic genes.
  • These vectors show significant promise for treating neurological conditions, genetic disorders, and cancer.
  • Their utility extends to vaccine development for various pathogens.